Avanos Medical reports Q2 mixed earnings; narrows FY22 guidance

Aug. 09, 2022 7:22 AM ETAvanos Medical, Inc. (AVNS)By: Meghavi Singh, SA News Editor
  • Avanos Medical press release (NYSE:AVNS): Q2 Non-GAAP EPS of $0.41 beats by $0.03.
  • Revenue of $203M (+8.9% Y/Y) misses by $5.28M.
  • Adjusted EBITDA for the second quarter was $33M, compared to $20M in the prior year period.
  • The company is modifying its guidance for 2022 net sales to between $815 million and $835 million vs. consensus of $841.40M, which assumes organic growth between 1 percent to 4 percent. Additionally, we are confirming gross profit margins to be between 55 percent to 57 percent, with adjusted diluted earnings per share between $1.45 and $1.65 vs. consensus of $1.64.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.